Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
HUGroup Holdings ( (JP:4544) ) has issued an announcement.
H.U. Group Holdings has revised its full-year consolidated earnings forecast for the fiscal year ending March 31, 2025, due to underperformance in its LTS and IVD businesses. The company expects operating profit to be significantly lower than previously forecasted, influenced by foreign exchange impacts and changes in profit categorization, though the year-end dividend forecast remains unchanged.
The most recent analyst rating on (JP:4544) stock is a Hold with a Yen2700.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.
More about HUGroup Holdings
H.U. Group Holdings, Inc. operates in the healthcare industry, focusing on laboratory testing services (LTS) and in vitro diagnostics (IVD). The company is listed on the Tokyo Stock Exchange and aims to provide innovative healthcare solutions.
Average Trading Volume: 203,663
Technical Sentiment Signal: Buy
Current Market Cap: Yen162.6B
See more insights into 4544 stock on TipRanks’ Stock Analysis page.